This notion led to the development of tumor cell vaccines like Lucanix, which expresses TGF-β2 AON, or Vigil that harbors a short hairpin RNAi targeting furin convertase, involved in TGF-β1 and TGF-β2 precursors processing [120]. The gene discussed is TGFB2; the disease is neoplasm.